The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.

The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.

It’s easy to read emotions on people’s faces — each one has its clear, unmistakable signature. But what about thoughts? A study published in Nature Neuroscience shows that mice’s problem-solving strategies can be deciphered from subtle facial movements. According to the authors, this is a proof of concept that the contents of the mind can be read out from video recordings, potentially offering powerful new research and diagnostic tools.   

John Krakauer is a John C. Malone Professor and Professor of Neurology, Neuroscience, and Physical Medicine and Rehabilitation at Johns Hopkins University, where he directs the Brain, Learning, Animation, and Movement Lab (BLAM Lab). He is also an External Professor at the Santa Fe Institute.

Host

Ibrahim Taştekin, PhD, Behavior and Metabolism Lab

Venue

Seminar room

Blending in-depth lectures with guided laboratory sessions, the workshop offered a dynamic introduction to core molecular biology techniques. Participants engaged directly with methods such as RNA extraction, cDNA synthesis, PCR, restriction enzyme digestion, electrophoresis, plasmid DNA isolation, sequence analysis, and experimental design for cloning projects.

By combining expert instruction with hands-on practice, the programme not only reinforced fundamental concepts but also fostered confidence in applying these tools to real-world research challenges.

The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring. 

The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.